Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injection After Arthroscopic Partial Meniscectomy
NCT04641351Phase 4Active, not recruiting
- Sponsor
- Cleveland Clinic
- Start
- May 2021
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of triamcinolone acetonide in osteoarthritis (OA), synovitis and Meniscus Tear (MT) (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Knee injury and Osteoarthritis Outcome Score at 3 months. Started May 2021; status: active, not recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis (OA)synovitisMeniscus Tear (MT)
Beyond the preview
Go deeper on NCT04641351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04641351.